Pictet Asset Management Holding SA Sells 11,485 Shares of GE HealthCare Technologies Inc. $GEHC

Pictet Asset Management Holding SA decreased its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 5.7% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 188,398 shares of the company’s stock after selling 11,485 shares during the quarter. Pictet Asset Management Holding SA’s holdings in GE HealthCare Technologies were worth $13,410,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds also recently made changes to their positions in GEHC. Laurel Wealth Advisors LLC bought a new position in GE HealthCare Technologies in the 4th quarter valued at approximately $26,000. Optima Capital LLC bought a new stake in shares of GE HealthCare Technologies in the 4th quarter worth $27,000. Godfrey Financial Associates Inc. bought a new stake in shares of GE HealthCare Technologies in the 4th quarter worth $27,000. Montag A & Associates Inc. raised its stake in shares of GE HealthCare Technologies by 105.4% in the fourth quarter. Montag A & Associates Inc. now owns 341 shares of the company’s stock worth $28,000 after purchasing an additional 175 shares during the last quarter. Finally, Transamerica Financial Advisors LLC raised its stake in shares of GE HealthCare Technologies by 331.6% in the fourth quarter. Transamerica Financial Advisors LLC now owns 341 shares of the company’s stock worth $28,000 after purchasing an additional 262 shares during the last quarter. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Stock Performance

GEHC stock opened at $65.57 on Friday. The company has a debt-to-equity ratio of 0.95, a current ratio of 1.22 and a quick ratio of 0.95. GE HealthCare Technologies Inc. has a 1 year low of $58.75 and a 1 year high of $89.77. The company has a market cap of $29.83 billion, a P/E ratio of 15.69, a price-to-earnings-growth ratio of 1.77 and a beta of 0.72. The stock’s fifty day moving average price is $63.82 and its 200-day moving average price is $73.34.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its earnings results on Wednesday, April 29th. The company reported $0.99 earnings per share for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.08). The firm had revenue of $5.13 billion during the quarter, compared to the consensus estimate of $5.04 billion. GE HealthCare Technologies had a net margin of 9.10% and a return on equity of 20.46%. The firm’s revenue was up 7.4% compared to the same quarter last year. During the same period in the prior year, the company posted $1.01 EPS. GE HealthCare Technologies has set its FY 2026 guidance at 4.800-5.000 EPS. On average, equities analysts forecast that GE HealthCare Technologies Inc. will post 4.89 earnings per share for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 14th. Stockholders of record on Friday, July 24th will be paid a $0.035 dividend. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. The ex-dividend date is Friday, July 24th. GE HealthCare Technologies’s dividend payout ratio is 3.35%.

Analysts Set New Price Targets

Several research firms recently commented on GEHC. Wall Street Zen cut GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, March 21st. Mizuho decreased their target price on GE HealthCare Technologies from $90.00 to $80.00 in a research report on Thursday, April 30th. The Goldman Sachs Group restated a “neutral” rating on shares of GE HealthCare Technologies in a research note on Monday, June 8th. BNP Paribas Exane dropped their price target on shares of GE HealthCare Technologies from $95.00 to $88.00 in a report on Friday, May 1st. Finally, Rothschild & Co Redburn reduced their price target on shares of GE HealthCare Technologies from $110.00 to $98.00 in a research note on Thursday, April 30th. Ten equities research analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. According to MarketBeat.com, GE HealthCare Technologies presently has a consensus rating of “Moderate Buy” and an average price target of $80.20.

Insider Buying and Selling

In other GE HealthCare Technologies news, CFO James Saccaro bought 3,310 shares of GE HealthCare Technologies stock in a transaction on Friday, May 1st. The stock was acquired at an average cost of $60.60 per share, with a total value of $200,586.00. Following the completion of the acquisition, the chief financial officer owned 87,471 shares in the company, valued at approximately $5,300,742.60. This represents a 3.93% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Peter J. Arduini purchased 4,169 shares of the firm’s stock in a transaction on Thursday, April 30th. The stock was acquired at an average price of $59.92 per share, for a total transaction of $249,806.48. Following the completion of the transaction, the chief executive officer directly owned 259,424 shares of the company’s stock, valued at approximately $15,544,686.08. This trade represents a 1.63% increase in their position. The SEC filing for this purchase provides additional information. Insiders have bought a total of 21,847 shares of company stock valued at $1,361,355 in the last 90 days. 0.36% of the stock is owned by insiders.

About GE HealthCare Technologies

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.